Sign in

CIK 0001668243

  • Non-accelerated filer
  • Smaller reporting company

UroGen Pharma Ltd.

Sign in to watch
Ticker
URGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
Phone
+972 97707601
Business address
9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,037,646
in 4 filings

Net −$3,037,646. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-01-31 Smith Jason Drew General Counsel Grant or award · Employee Stock Option (right to buy) +40,000 40,000
2023-01-31 Schoenberg Mark Chief Medical Officer Option exercise +500 147,127
2023-01-31 Schoenberg Mark Chief Medical Officer Sale −248 $10.12 $3K 146,879
2023-01-31 Schoenberg Mark Chief Medical Officer Option exercise +2,000 148,879
2023-01-31 Schoenberg Mark Chief Medical Officer Sale −991 $10.12 $10K 147,888
2023-01-31 Schoenberg Mark Chief Medical Officer Option exercise +1,333 149,221
2023-01-31 Schoenberg Mark Chief Medical Officer Sale −661 $10.12 $7K 148,560
2023-01-31 Schoenberg Mark Chief Medical Officer Option exercise · Restricted Stock Units −500 0
2023-01-31 Schoenberg Mark Chief Medical Officer Option exercise · Restricted Stock Units −2,000 2,000
2023-01-31 Schoenberg Mark Chief Medical Officer Option exercise · Restricted Stock Units −1,333 2,667
2023-01-31 Schoenberg Mark Chief Medical Officer Grant or award · Restricted Stock Units +10,000 10,000
2023-01-31 Schoenberg Mark Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +30,000 30,000
2023-01-20 Schoenberg Mark Chief Medical Officer Option exercise +122,677 $5.00 $613K 146,627
2023-01-20 Schoenberg Mark Chief Medical Officer Option exercise · Employee Stock Option (right to buy) −122,677 0
2022-11-08 Wildman Daniel George Director Grant or award · Stock Option (right to buy) +20,000 20,000
2022-10-31 Schoenberg Mark Chief Medical Officer Option exercise +500 24,208
2022-10-31 Schoenberg Mark Chief Medical Officer Sale −258 $11.85 $3K 23,950
2022-10-31 Schoenberg Mark Chief Medical Officer Option exercise · Restricted Stock Units −500 500
2022-10-21 Nussbaum Ran Director Option exercise +47,999 $5.94 $285K 1,485,168
2022-10-21 Nussbaum Ran Director Option exercise · Stock Option (right to buy) −32,723 0

Page 11 of 13 · 244 trades